We are live on
!
Find out more
CAN
Claraphi Advisory Network Portfolio holdings
AUM
$251M
Turnover
51.06%
1-Year Est. Return
9.29%
This Fund
S&P 500
This Quarter
Est. Return
+4.12%
1 Year Est. Return
-9.29%
3 Year Est. Return
+88.33%
5 Year Est. Return
+135.31%
10 Year Est. Return
–
AUM
$155M
AUM Growth
+$13.9M
(+9.8%)
Cap. Flow
+$9.72M
Cap. Flow
% of AUM
6.27%
Top 10 Holdings %
Top 10 Hldgs %
23.12%
Holding
295
New
39
Increased
101
Reduced
106
Closed
28
Avg Time Held
0.4
years
Top 10 Avg Time Held
0.3
years
Top 20 Avg Time Held
0.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Bloomberg Convertible Securities ETF
CWB
|
+$10.3M |
| 2 |
ARK Innovation ETF
ARKK
|
+$2.16M |
| 3 |
Alerian MLP ETF
AMLP
|
+$1.09M |
| 4 |
BlackRock Resources & Commodities Strategy Trust
BCX
|
+$756K |
| 5 |
Vanguard High Dividend Yield ETF
VYM
|
+$540K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
abrdn Life Sciences Investors
HQL
|
+$2.64M |
| 2 |
Nuveen S&P 500 Buy-Write Income Fund
BXMX
|
+$1.94M |
| 3 |
State Street SPDR S&P Biotech ETF
XBI
|
+$553K |
| 4 |
Invesco Financial Preferred ETF
PGF
|
+$551K |
| 5 |
Meta Platforms (Facebook)
META
|
+$482K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 47.15% |
| 2 | Technology | 11.9% |
| 3 | Healthcare | 7.01% |
| 4 | Financials | 5.78% |
| 5 | Consumer Discretionary | 5.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
26
Boeing
BA
$149B
| $1.18M | 0.76% |
3,513
+58
| +2% | +$19.9K |
2017 Q4
2 quarters
|
|
27
First Trust NASDAQ-100 Technology Index Fund
QTEC
$3.83B
| $1.18M | 0.76% |
15,260
+3,595
| +31% | +$280K |
2017 Q4
2 quarters
|
|
28
Intel
INTC
$504B
| $1.17M | 0.75% |
23,454
+1,960
| +9% | +$104K |
2017 Q4
2 quarters
|
|
|
29
abrdn Life Sciences Investors
HQL
$524M
| $1.16M | 0.75% |
61,869
-140,499
| -69% | -$2.64M |
2017 Q4
2 quarters
|
|
|
30
Vanguard High Dividend Yield ETF
VYM
$81.4B
| $1.12M | 0.72% |
13,463
+6,450
| +92% | +$540K |
2017 Q4
2 quarters
|
|
31
ConocoPhillips
COP
$170B
| $1.12M | 0.72% |
16,062
+1,353
| +9% | +$90.1K |
2017 Q4
2 quarters
|
|
32
iShares Core S&P 500 ETF
IVV
$889B
| $1.1M | 0.71% |
4,041
-766
| -16% | -$208K |
2017 Q4
2 quarters
|
|
|
33
Alerian MLP ETF
AMLP
$12.5B
| $1.09M | 0.7% |
+21,505
| New | +$1.09M |
2018 Q2
0 quarters
|
|
34
Berkshire Hathaway Class B
BRK.B
$1.13T
| $1.04M | 0.67% |
5,567
-168
| -3% | -$32.7K |
2017 Q4
2 quarters
|
|
35
iShares MSCI USA Min Vol Factor ETF
USMV
$24.1B
| $1.04M | 0.67% |
19,489
-3,301
| -14% | -$174K |
2017 Q4
2 quarters
|
|
36
Alibaba
BABA
$276B
| $1.02M | 0.66% |
5,496
-502
| -8% | -$95.7K |
2017 Q4
2 quarters
|
|
|
APTS
37
DELISTED
Preferred Apartment Communities, Inc.
APTS
| $1.01M | 0.65% |
60,172
+4,606
| +8% | +$67.9K |
2017 Q4
2 quarters
|
|
38
KKR Income Opportunities Fund
KIO
$408M
| $996K | 0.64% |
60,168
+20,114
| +50% | +$325K |
2017 Q4
2 quarters
|
|
39
iShares Core S&P Mid-Cap ETF
IJH
$123B
| $980K | 0.63% |
25,155
-4,450
| -15% | -$172K |
2017 Q4
2 quarters
|
|
40
NVIDIA
NVDA
$5.25T
| $949K | 0.61% |
160,200
+960
| +0.6% | +$5.83K |
2017 Q4
2 quarters
|
|
41
ExxonMobil
XOM
$718B
| $907K | 0.59% |
10,961
-1,074
| -9% | -$85.6K |
2017 Q4
2 quarters
|
|
42
General Dynamics
GD
$91.2B
| $860K | 0.55% |
4,612
+46
| +1% | +$9.42K |
2017 Q4
2 quarters
|
|
43
Invesco QQQ Trust
QQQ
$487B
| $859K | 0.55% |
5,006
+30
| +0.6% | +$5.03K |
2017 Q4
2 quarters
|
|
|
ABMD
44
DELISTED
Abiomed Inc
ABMD
| $859K | 0.55% |
2,099
+48
| +2% | +$17.4K |
2017 Q4
2 quarters
|
|
45
Pfizer
PFE
$168B
| $857K | 0.55% |
24,907
+986
| +4% | +$33.7K |
2017 Q4
2 quarters
|
|
46
Southern Company
SO
$103B
| $849K | 0.55% |
18,341
+4,558
| +33% | +$204K |
2017 Q4
2 quarters
|
|
|
ATVI
47
DELISTED
Activision Blizzard
ATVI
| $831K | 0.54% |
10,886
-5,082
| -32% | -$360K |
2017 Q4
2 quarters
|
|
48
Northern Trust Ultra-Short Fixed Income ETF
RAVI
$1.6B
| $830K | 0.54% |
11,011
-3,939
| -26% | -$297K |
2017 Q4
2 quarters
|
|
49
Verizon
VZ
$184B
| $815K | 0.53% |
16,200
+2,151
| +15% | +$104K |
2017 Q4
2 quarters
|
|
50
Merck
MRK
$358B
| $810K | 0.52% |
13,982
-340
| -2% | -$19.2K |
2017 Q4
2 quarters
|
|
Similar funds
JW
A
APP
RW
SCM
ACMV
GTCM
CDIA
Claraphi Advisory Network's Q2 2018 Portfolio in Review
As of Q2 2018, Claraphi Advisory Network held 295 positions worth $155M, up 9.8% from $141M the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Claraphi Advisory Network deployed $9.72M of net new capital in Q2 2018, opening 39 new positions and adding to 101 existing holdings. Its largest new stake was ARK Innovation ETF: 50,557 shares worth $2.27M.
By sector, the portfolio is most concentrated in Miscellaneous at 47% of assets, up from 45% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was abrdn Life Sciences Investors, an estimated $2.64M trimmed.
- Claraphi Advisory Network's largest Q2 2018 buy was ARK Innovation ETF: 50,557 shares worth $2.27M.
- Claraphi Advisory Network added most to State Street SPDR Bloomberg Convertible Securities ETF in Q2 2018, an estimated $10.3M increase.
- Claraphi Advisory Network's biggest Q2 2018 reduction was abrdn Life Sciences Investors, cutting an estimated $2.64M.
- Claraphi Advisory Network fully exited Deere & Co in Q2 2018, selling an estimated $373K.
- Claraphi Advisory Network's ten largest holdings make up 23% of its $155M portfolio in Q2 2018.
- Claraphi Advisory Network opened 39 new positions and closed 28 in Q2 2018.
- Claraphi Advisory Network's portfolio value rose 9.8% quarter-over-quarter to $155M.
Based on Claraphi Advisory Network's 13F filing for Q2 2018, filed 14 Aug 2018.